Type 1 Diabetes Mellitus
- Accounts for 8% of all diabetes cases
- Risk factors
-
- Genetics – 50% risk in identical twins, 6% risk in sibling, 5% risk if parent affected
- Diet, vitamin D deficiency, obesity, viral infections
-
- Associated with other autoimmune disorders
-
- Especially thyroid disease (Graves or Hashimotos) in 22%, also pernicious anaemia, coeliacs, vitiligo, Addison’s.
- Check TFTs and coeliac antibodies routinely in all type 1 diabetics
-
- Reduces life expectancy by around 12 years on average
- Onset
-
- Peaks from 6 months old to 5 years, and then again in puberty
- 30% occurs in adulthood (suspect especially if there is autoimmunity and a lean patient)
- If not clear-cut diagnosis, check autoantibodies (see diagnosing diabetes)
-
- General management
-
- Individualised care plan
- Similar lifestyle advice as T2DM
- DAFNE – a course to help T1DM adjust their insulin according to diet
-
- DAFNE / dietary advice
-
- Carb counting involves dividing carbohydrates consumed by a patient specific ratio to calculate the units insulin required
- Can use the Carbs and cals app
- Every 10g carbs is one Carbohydrate Portion (CP) – so if 1:1 ratio, 40g carbs = 4 CPs = 4 units of insulin.
- Sometimes 1:10 ratio quoted instead (ie 10g of carbs for every unit of insulin) – this is the starting ratio for most type one diabetics
- Examples of carbohydrate content / portion
-
- 1 medium slice of bread 15g
- A panini 50g
- A jacket potato 50g
- A banana 25g
- An apple 15
- Cooked pasta is 1/3 of it’s weight (so 150g is 50g carbs)
- I pint milk 30g
-
- Fat and protein also effect sugar levels – ratios: carbs 1:10, protein 1:40, fat 1:30.
- Carb counting takes time… usually not taught as an inpatient
- Ensure diabetics get the right nutritional supplements in hospital if required (eg Fresubin protein energy, not the 2 kcal fresubin or energy fresubin which can cause high sugars (and are more usually used in malnutrition)
- Do not advise low glycaemic index diet for glucose control
-
- Exercise advice
-
- A long acting insulin like Levemir is probably best for very active type 1 diabetics who exercise a lot
- A patient can change their insulin ratio depending on when they exercise
- Don’t exercise if CBGs outside 7 – 15 (and if 4-6.9, delay and eat)
- Exercising after 4pm increases the risk of going hypoglycaemic overnight
- Patients should always take hypo-treatment with them when exercising
- Take complex carbs up to 2 hours before exercise and simple carbs within 2 hours.
-
- Targets
-
- Usually target HbA1c of <48
- If CKD (not on dialysis) – aim <48 to <64, depends on the person
- Check HbA1c every 3-6 months
- Target CBGs 5-7 before breakfast, 4-7 before other meals and 5-9 before bed
- For time in range (TIR) targets – see diabetes tech
-
- Offer Continuous Glucose Monitoring (CGM, either real-time or scanned)
-
- Patients still need to check occasional CBGs to check accuracy of sensor (and as back up)
- See diabetes tech
-
- If checking fingerprick CBGs
-
- Advise to check at least 4 x day
- Check up to 10 times daily if poor control, planning pregnancy/pregnant, exercising a lot, unwell, impaired hypoglycaemic awareness, driving long distance
-
- Medications in type 1 DM
-
- Metformin can be given to T1DM with BMI > 25
- SGLT2is are contraindicated
- Statins offered to all type 1 diabetics aged >40
- ACE-I / ARB given if CKD, albuminuria or hypertension
-
- Basal-bolus regime
-
- Rapid/short acting before meals (not after) + once or twice daily intermediate/long acting insulin
- Offers good flexibility for glucose control
- Get basal dose right first, then adjust short-acting
- If long-acting insulin needs increasing – go up by 2 units
- If you don’t know the dose of basal insulin in a diabetic patient being admitted, just give 10 units of lantus and figure it out later
- See insulin for more detail
-
- Mixed / biphasic
-
- Once to three times daily doses of combination insulin
- Not advised for newly diagnosed T1DM
- Sometimes used if basal bolus regime not possible
-
- Consider pump therapy / closed loops
-
- Gives regular short acting insulin, no need for long acting
- More expensive, but closely matches insulin requirements to individual
- Recommended if disabling hypoglycaemia when trying to achieve HbA1c target, or HbA1c >69 despite a high level of care
- See diabetes tech
-
Type 2 Diabetes
- 90% of diabetes cases. Affects more than 5 million adults in the UK, and 20% of hospital inpatients
- > 100 children diagnosed with type 2 DM every year in the UK
- Higher prevalence in ethnic minorities (especially those from the Indian subcontinent)
- Around one million people in the UK with T2DM are undiagnosed
- Decline in beta cell function is already advanced at time of diagnosis (begins around a decade before – ‘pre-diabetes’)
- Life expectancy in type 2 DM is reduced by around 10 years (deprivation adjusted standardised mortality rate in T2DM is around 1.5)
- Multifactorial aetiology
-
- Not just due to reduced insulin sensitivity
- Increased glucagon secretion, lipolysis, glucose reabsorption and hepatic glucose production (esp overnight, so higher sugars in the morning)
- Decreased glucose uptake, insulin secretion, incretin effect
- Impaired appetite regulation
-
- Risk factors
-
- Obesity – accounts for around 80% of the risk
- Family history – 4x greater risk. 15% risk if one parent has T2DM, 75% if both
- Ethnicity – 3x greater risk if Asian, African/Afro-Caribbean
- History of gestational DM – 7 x increased risk
- High glycaemic index diet (independent of weight gain)
- Medications
- Polyendocrine metabolic ovarian syndrome (PMOS)
- If born before 35 weeks gestation
-
- Prevention – weight loss and lifestyle modification best
-
- Weight loss of 15kg in DM over 12 months equates to an 86% chance of remission, 10-15kg = 57% chance, 5-10kg = 34% chance and 0-5kg = 7% chance
- Recommended diet: high fibre, low glycaemic index carbs, low fat, oily fish
- Avoid high salt and high glycaemic index carbs
- Regular exercise
-
- HbA1c Targets
-
- Target 48-58 for most – eg if micoalbuminuria, age <40 or duration of DM < 10 years
- Target HbA1c of 48 if diet-controlled or on single drugs not associated with hypoglycaemia (like metformin)
- Target HbA1c 53 if on sulphonylurea
- Target 58-62 if CKD stage 3 or 4, or albuminuria
- Target 58-68 if CKD stage 5 or on dialysis
- If HbA1c > 58 – consider escalating treatment (but also check adherence)
- Consider higher HbA1c targets if person at risk of falls, impaired hypoglycaemic awareness, drivers, reduced life expectancy
-
- Monitoring
-
- Self-monitoring CBGs is not routine, but should be used if on insulin or sulfonylurea, previous hypoglycaemia, pregnant
- Continuous Glucose Monitoring used in T2DM if on insulin and any of:
-
- Recurrent hypos
- Impaired hypo awareness
- Certain disabilities
- Would otherwise require checking CBGs >8x day
- Would otherwise need a carer to monitor CBGs
-
- A 1% reduction in HbA1c is associated with a 14% reduction in MI, 37% reduction in microvascular complications and a 21% reduced risk of DM-related death
-
- Drugs in T2DM – see diabetes medications and glucose control
- If starting insulin in T2DM
-
- 1st line is NPH (neutral protamine Hagedorn) – once or twice daily
- NPH + short acting (separate or premixed) – if HbA1c >75
- Consider determir or glargine as alternative to NPH (sometimes easier). Switch to one of these from NPH if there’s hypoglycaemia
-
Other forms of diabetes mellitus
- MODY (maturity onset diabetes of the young) / monogenic DM
-
- Often a young, lean person with mild hyperglycaemia and a strong family history of diabetes diagnosed at a young age. More common in women.
- Do genetic testing
- No autoimmune markers
- Exquisitely sensitive to sulphonylureas and often maintain excellent glycaemic control for years on these medications. May not need insulin.
- Prevalence of 3 antibodies is <1% (can help discriminate)
-
- LADA (latent autoimmune diabetes in adults)
-
- Suspect (LADA) in a middle aged, lean patient with hyperglycaemia
- Shares traits of T1DM and T2DM. Behaves like an insidious presentation of T1
- Often have autoantibodies especially GAD65
- C peptide often low and are often used to guide treatment strategies
-
- Ketosis-prone DM
-
- More common in an overweight, non-white patient with DKA (and especially common in black men)
- Often insulin can be discontinued after a few months
-
- Haemochromatosis – an uncommon cause of diabetes. Look for other features. More here
- Pancreatic (type 3c)
-
- Underdiagnosed, could represent 8% of DM
- Consider CT pancreas if older, losing weight and appears to be T1DM
- Causes
-
- Acute pancreatitis
- Chronic pancreatitis
- Carcinoma
- Haemochromatosis
- Cystic fibrosis
- Surgery
-
-
- Gestational diabetes – more here
- MIDD (Maternally inherited DM and deafness) – mitochondrial inheritance
- Drug-induced
-
- Steroids – more here
- Betablockers, diuretics (high dose thiazides), statins, oral contraceptive – all cause small increases in blood sugar
- Antipsychotics (especially clozapine, olanzapine and quetiapine)
- Antiretrovirals
- Post-transplant drugs
- Tyrosine kinase inhibitors
- Interferon alpha
-
- Endocrine
-
- Cushing’s syndrome
- Acromegaly
- Glucagonoma, somatostatinoma
- Hyperthyroidism
- Phaeochomocytoma
-
Diabetes education
- Adherence to medications and insulin (and entitlement to free prescriptions)
- Sick day rules
-
- Stop ACE-I, ARBs, NSAIDs due to risk of AKI
- Stop metformin if risk of dehydration
- Stop SGLT-2 inhibitors (and check ketones)
- Stop GLP-1 receptor agonists if risk of dehydration
- Increase CBG monitoring
- Adjust insulin
- For type 1DM – never omit insulin entirely, check CBGs more frequently including though the night, check ketones
-
- Hypo avoidance (consider medic alert especially for type 1)
- DVLA advice (more here)
- Pregnancy / planning pregnancy (more here)
- Monitoring – HbA1c every 3-6 months in type 2 until stable, then every 6-12
- Diet, exercise, weight loss, smoking
- DAFNE (type 1), DESMOND (type 2)
- Fasting – avoid in T1DM, especially if poorly controlled
Diabetes clinic – screening and assessment
- Glycaemic control – HbA1c / time in range, medications/adherence, monitoring, injection sites, current treatment
- CV risk – Blood pressure, lipids, smoking, CV risk (if high, SGLT2 inhibitors particularly useful)
- Kidneys – Serum creatinine and Urine ACR (annually after diagnosis in T2DM, and more frequently if sharp decline, and annually after 5 years from diagnosis in T1DM) – often not monitored enough
- Feet
- Retinal screen
- BMI and diet
- Immunisations – flu, pneumococcus, covid